Overview

Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is the evaluation of the therapeutic benefit of intratympanic AM 101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus following acute sensorineural hearing loss.
Phase:
Phase 2
Details
Lead Sponsor:
Auris Medical AG